Ad Law Tool Kit Show – Episode 11 – State Attorney General Investigations
Compliance Tip of the Day: Cross Border Investigations, Part 1
Better Investigative Interviewing
What to Do If the Government Knocks on Your Company’s Door … or Breaks It Down – Speaking of Litigation Podcast
Bank Investigations and Enforcement Actions: Lessons Learned — The Consumer Finance Podcast
PLI's inSecurities Podcast - Opening the Securities Enforcement Answer Book
AGG Talks: Antitrust and White-Collar Crime Roundup - The Mar-a-Lago Trump Indictment
AGG Talks: Antitrust and White-Collar Crime Roundup - Inside the World of No-Poach Investigations and Indictments
Healthcare Providers: Make Sure You Know When You Need a Criminal Attorney
Why Your Data is Key to Reducing Risk and Increasing Efficiency During Investigations and Litigation
State AG Pulse | State AGs and Feds: The Dynamics of Influence & Collaboration
The Risk Roundtable: Pre-Existing Conditions and Abdullah Credits in New Jersey Workers' Compensation
The Justice Insiders Podcast: Feds Danske to a New Tune
The Rules They Are A-Changin’: CMS Proposes a Significant Change to the 60-Day Repayment Rule
Predatory Behavior Alleged Against OSHA Addressed During Orange County Board of Education Board Meeting Led by Greg Rolen
Early Returns with Jan Baran Podcast: There's a New Chair in Town – Dara Lindenbaum and the FEC Agenda Looking Towards 2024
Evaluating Fraud Under the Bank Secrecy Act - The Crypto Exchange Podcast
How Law Firms and Lobbyists Can Work Together: A Look Into Lobbyists’ Role Among State AGs - Regulatory Oversight Podcast
Torres Talks Trade Podcast- Episode 13- When Government Agencies Come Knocking
Keeping Up With the Bureau Episode 1: Overview of CFPB and State AG Initiatives/Expansion - The Consumer Finance Podcast
The government continued to dedicate enormous resources to investigating and prosecuting fraud against COVID-19 pandemic relief programs in 2023. While we observed some civil False Claims Act settlements, criminal enforcement...more
The “epidemic” of COVID-19 related fraud continued unabated in 2022, and we expect to see the same in 2023. The Department of Justice (DOJ) appears poised to continue to aggressively investigate and prosecute COVID-19-related...more
In a December 12, 2017 Advisory Board article, “The 340B drug pricing controversy, explained,” Scott Orwig wrote, “the 340B Drug Pricing Program is one of the most contentious issues in health care: Its critics say it ‘hurts...more
On Friday October 31, 2014, the U.S. Department of Health & Human Services (HHS) Office of Inspector General (OIG) released its annual “Work Plan” for fiscal year 2015. The Work Plan is a compilation of the OIG’s plans for...more